会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • 한국에서 분리한 일본뇌염 VIRUS의 PRM 과 ENVELOPE GENE을 이용한 재조합 DNA 백신
    • 空值
    • KR100252380B1
    • 2000-04-15
    • KR1019970058165
    • 1997-11-05
    • 대한민국(관리부서 질병관리본부장)
    • 조해월남재환고현철이호동
    • C12N15/85C12N15/33
    • PURPOSE: Provided is a recombinant DNA vaccine using PrM and envelope gene of Japanese encephalitis virus (JEV) isolated from Korea. Therefore, the infection with Japanese encephalitis is protected effectively, its immunity is maintained for long time and vaccination against Japanese encephalitis is easily manufactured. CONSTITUTION: A recombinant DNA vaccine using an expression vector pPCJE-1PrM is prepared by the following steps of: (a) selecting vaccine virus being appropriate to Korea by comparing serologic and genetic features between JEV 5 strains (K96P20, K94P05, K91P55, K87P39, K82P01) isolated from Korea and Nakayama-NIH strain and other JEV isolated from Asia; (b) making a recombinant vaccine using vector system; and (c) identifying the expression of antigen, creating antibody according to animal immunity and defending mechanism by using the novel recombinant vaccine.
    • 目的:提供使用从韩国分离的日本脑炎病毒(JEV)的PrM和包膜基因的重组DNA疫苗。 因此,日本脑炎感染得到有效保护,其免疫力长期保持,容易制造针对日本脑炎的疫苗接种。 构成:使用表达载体pPCJE-1PrM的重组DNA疫苗通过以下步骤制备:(a)通过比较JEV 5菌株(K96P20,K94P05,K91P55,K87P39,K87P39)的血清学和遗传特征,选择适合于韩国的疫苗病毒, K82P01)和中山NIH菌株和从亚洲分离的其他JEV; (b)使用载体系统制备重组疫苗; 和(c)通过使用该新型重组疫苗,鉴定抗原的表达,根据动物免疫和防御机制产生抗体。
    • 2. 发明公开
    • 사스 코로나바이러스 뉴클레오캡시드 단백질에 대한 단클론항체 및 이것의 용도
    • 针对非典型肺炎克雷伯菌的核苷酸蛋白的单克隆抗体及其用途
    • KR1020070103547A
    • 2007-10-24
    • KR1020060035230
    • 2006-04-19
    • 대한민국(관리부서 질병관리본부장)
    • 강춘조해월정윤석신구철
    • C07K16/00C07K16/30
    • C07K16/10C12Y111/01007G01N33/535G01N33/56983G01N2333/165
    • A monoclonal antibody against nucleocapsid protein of SARS(severe acute respiratory syndrome) coronavirus is provided to improve affinity with SARS coronavirus nucleocapsid(N) antigen, and exhibit no cross reactivity for human coronavirus serum. A monoclonal antibody against nucleocapsid(N) antigen of SARS coronavirus is produced from a hybridoma cell(KCLRF-BP-00126) which is produced by fusing a spleen cell of a mouse immunized by the SARS coronavirus nucleocapside antigen with a myeloma cell and reacts with regions of 135th-150th amino acids and 17th-32th amino acids from the amino terminal of nucleocapsid(N) antigen of SARS coronavirus. A diagnostic kit for diagnosis of SARS coronavirus comprises the monoclonal antibody against nucleocapsid protein of SARS coronavirus, an antibody coupled with a marker capable of coloring by reacting with a substrate, and a coloring substrate, wherein the marker is HRP(horse radish peroxidase) or FITC(fluorescein isothiocyanate), and the coloring substrate is TMB(3,3',5,5'-tetramethylbenzidine).
    • 提供针对SARS(严重急性呼吸综合征)冠状病毒核衣壳蛋白的单克隆抗体,以改善与SARS冠状病毒核衣壳(N)抗原的亲和力,并且对人冠状病毒血清没有交叉反应性。 通过将由SARS冠状病毒核壳抗原免疫的小鼠的脾细胞与骨髓瘤细胞融合产生的杂交瘤细胞(KCLRF-BP-00126)产生抗SARS冠状病毒的核衣壳(N)抗原的单克隆抗体,并与 来自SARS冠状病毒的核衣壳(N)抗原的氨基末端的第135-150个氨基酸和第17个到第32个氨基酸的区域。 用于诊断SARS冠状病毒的诊断试剂盒包括针对SARS冠状病毒的核衣壳蛋白的单克隆抗体,与能够通过与底物反应着色的标记的抗体和着色底物,其中所述标记是HRP(辣根过氧化物酶)或 FITC(异硫氰酸荧光素),着色底物是TMB(3,3',5,5'-四甲基联苯胺)。
    • 3. 发明授权
    • 한국에서 분리된 일본뇌염 바이러스의 염기서열
    • 空值
    • KR100252379B1
    • 2000-04-15
    • KR1019970041452
    • 1997-08-27
    • 대한민국(관리부서 질병관리본부장)
    • 조해월남재환
    • C12N15/33
    • PURPOSE: Provided are PrM sequence and base sequence of envelope genes of Japanese encephalitis virus (JEV) 5 strains (K96P10, K94P05, K91P55, K87P39, K82P01) isolated from Korea. And base sequence and amino acid sequence of entire genome of K94P05 strain are also provided, which are used in preparing recombinant vaccine. CONSTITUTION: PrM sequence and base sequence of envelope gene of Japanese encephalitis virus (JEV) 5 strains is identified by the identification of serologic discrepancy between strains isolated form Korea and the other strain by Cross-hemagglutination inhibition test and the identification of the base sequence of the envelope gene of the strains isolated form Korea.
    • 目的:提供从韩国分离的日本脑炎病毒(JEV)5株(K96P10,K94P05,K91P55,K87P39,K82P01)的包膜基因的PrM序列和碱基序列。 还提供了K94P05菌株全基因组的碱基序列和氨基酸序列,用于制备重组疫苗。 构成:日本脑炎病毒(JEV)5株的包膜基因的PrM序列和碱基序列通过鉴定从韩国分离的菌株与其他菌株之间的血清学差异来鉴定,通过交叉血凝抑制试验和基因序列的鉴定 从韩国分离的菌株的包膜基因。
    • 6. 发明授权
    • 호흡기 바이러스 검출용 올리고뉴클레오타이드 및 DNA칩
    • 用于检测呼吸道病毒的寡核苷酸和DNA芯片
    • KR100832860B1
    • 2008-05-30
    • KR1020060128397
    • 2006-12-15
    • 대한민국(관리부서 질병관리본부장)
    • 조해월이주실강춘김기순최우영정윤석최장훈
    • C12Q1/68
    • Y02A50/451C12Q1/6888C12Q1/6834C12Q1/6837C12Q1/70C12Q2537/143C12Q2563/107
    • A DNA chip is provided to detect 8 kinds of respiratory virus at the same time, show excellent sensitivity and specificity and diagnose infection by PIV1, PIV2, PIV3, RSV A, RSV B, HcoV(229E), HcoV(OC43) and SARS virus rapidly by omitting a subsequent PCR process, thereby being very usefully used for preparing a diagnosis reagent or a diagnosis kit for the virus infection. An oligonucleotide DNA chip for detecting respiratory virus is characterized in that oligonucleotide probes having nucleotide sequences of SEQ ID : NOs. 1 to 8 are immobilized on a slide, wherein each of the probes is specifically coupled to a HA gene of PIV1, a HA gene of PIV2, a HA gene of PIV3, an N gene of RSV A, an N gene of RSV B, an M gene of HcoV(229E), an M gene of HcoV(OC43), and an N gene of SARS. A kit for detecting the respiratory diseases comprises: the oligonucleotide DNA chip; and a marking means which detects hybridization reaction of cDNA synthesized from a sample RNA obtained from the probe of the DNA chip and a test body, wherein the marking means a fluorescent material including cy5-dUTP.
    • 提供DNA芯片同时检测8种呼吸道病毒,显示出优异的灵敏度和特异性,并诊断PIV1,PIV2,PIV3,RSV A,RSV B,HcoV(229E),HcoV(OC43)和SARS病毒感染 通过省略随后的PCR过程,从而非常有用地用于制备用于病毒感染的诊断试剂或诊断试剂盒。 用于检测呼吸道病毒的寡核苷酸DNA芯片的特征在于具有SEQ ID NO: 1至8被固定在载玻片上,其中每个探针特异性偶联于PIV1的HA基因,PIV2的HA基因,PIV3的HA基因,RSV A的N基因,RSV B的N基因, HcoV(229E)的M基因,HcoV(OC43)的M基因和SARS的N基因。 用于检测呼吸系统疾病的试剂盒包括:寡核苷酸DNA芯片; 以及标记装置,其检测从获自DNA芯片的探针和测试体的样品RNA合成的cDNA的杂交反应,其中所述标记是指包括cy5-dUTP的荧光材料。
    • 7. 发明公开
    • 사스 코로나바이러스 뉴클레오캡시드 단백질에 대한 단클론항체 및 이것의 용도
    • 针对非典型肺炎克雷伯菌的核苷酸蛋白的单克隆抗体及其用途
    • KR1020070103548A
    • 2007-10-24
    • KR1020060035231
    • 2006-04-19
    • 대한민국(관리부서 질병관리본부장)
    • 강춘조해월정윤석신구철
    • C07K16/00C07K16/10
    • C07K16/10C12Y111/01007G01N33/535G01N33/56983G01N2333/165
    • A monoclonal antibody against nucleocapsid antigen of SARS(severe acute respiratory syndrome) coronavirus is provided to improve sensitivity and specificity against SARS coronavirus, thereby being useful for diagnosis and prevention of SARS coronavirus infection. A hybridoma cell(KCLRF-BP-00127) producing a monoclonal antibody against nucleocapsid antigen of SARS coronavirus is produced by immunizing a mouse with a nucleocapsid antigen of SARS coronavirus(SEQ ID NO:1), collecting a spleen cell from the immunized mouse, fusing the spleen cell with a myeloma cell, cloning hybridoma cell by using limited dilution method to obtain a hybridoma cell clone producing a monoclonal antibody against only an epitope, wherein the monoclonal antibody against nucleocapsid antigen of SARS coronavirus reacts with a region consisting of 215th-239th amino acids from the amino terminal of nucleocapsid antigen of SARS coronavirus(SEQ ID NO:1).
    • 提供针对SARS(严重急性呼吸综合征)冠状病毒的核衣壳抗原的单克隆抗体,以提高对SARS冠状病毒的敏感性和特异性,从而可用于诊断和预防SARS冠状病毒感染。 通过用SARS冠状病毒(SEQ ID NO:1)的核衣壳抗原免疫小鼠,从免疫的小鼠收集脾细胞,产生产生针对SARS冠状病毒的核衣壳抗原的单克隆抗体的杂交瘤细胞(KCLRF-BP-00127) 将脾细胞与骨髓瘤细胞融合,通过使用有限稀释法克隆杂交瘤细胞以获得产生仅针对表位的单克隆抗体的杂交瘤细胞克隆,其中针对SARS冠状病毒的核衣壳抗原的单克隆抗体与由215bp组成的区域反应, 来自SARS冠状病毒的核衣壳抗原的氨基末端的第239个氨基酸(SEQ ID NO:1)。